Loading insider details...
Beta
Latest Form 4 (Aug 14, 2026): Exercise/Conversion of 750 SUPN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 14, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Exercise/Conversion | 750 | n/a |
| Jul 31, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 750 | n/a |
| Feb 26, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 1,250 | n/a |
| Feb 25, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 1,125 | n/a |
| Feb 20, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 13,500 | n/a |
| Sep 26, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Exercise/Conversion | 1,875 | n/a |
| Sep 12, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 1,875 | n/a |
| Mar 5, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Tax Withholding | 314 | $10.4K |
| Feb 25, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Exercise/Conversion | 1,875 | n/a |
| Feb 21, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 20,000 | n/a |